9 reports

  • Heart Transplant Rejection - Overview
  • Heart Transplant Rejection - Therapeutics Development

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Heart Transplant
  • Medical Biotechnology
  • Pharmaceutical
  • Transplantation
  • Astellas Pharma Inc.
  • Heart Transplant Rejection - Overview
  • Heart Transplant Rejection - Therapeutics Development

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Heart Transplant
  • Medical Biotechnology
  • Pharmaceutical
  • World
  • Product Initiative
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF HEART TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS
  • HEART TRANSPLANT REJECTION THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY PHASE (%), 2017*

HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* CLINICAL TRIALS BY END POINT STATUS HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* HEART TRANSPLANT REJECTION

  • Clinical Trial
  • Heart Transplant
  • Pharmaceutical
  • Transplantation
  • Novartis AG

Heart Transplantation Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Heart Transplantation Trials ## Clinical Trials Trends to 2022 ##. ## Ongoin

  • Clinical Trial
  • Drug Development
  • General Medicine And Specialty Medicine
  • Heart Transplant

Heart Transplant Rejection Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Heart Transplant Rejection Trials ## Clinical Trials Trends to 2022

  • Clinical Trial
  • Drug Development
  • General Medicine And Specialty Medicine
  • Heart Transplant

Insights into Heart Transplant Rejection Pipeline ##.

  • General Medicine And Specialty Medicine
  • Heart Transplant
  • World

2019 Heart Transplant Rejection Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Clinical Trial
  • Drug Development
  • General Medicine And Specialty Medicine
  • Heart Transplant

2019 Heart Transplant Rejection Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Clinical Trial
  • Drug Development
  • General Medicine And Specialty Medicine
  • Heart Transplant
  • APAC
  • JUL 13, 2017: CAREDX PROVIDES 100,000TH ALLOMAP TO HEART TRANSPLANT PATIENTS
  • FEB 05, 2018: CAREDX LEADERSHIP IN CFDNA HIGHLIGHTED AT CEOT

More than ##% of US heart transplant centers are now using the guidelinerecommended AlloMap for heart transplant patient surveillance.

  • Heart Transplant
  • United States
  • Company
  • Company Financials
  • CareDx, Inc.